Botanical Specialist Linnea Scores Narcotics License To Produce, Export High THC

January 17, 2023 · Bezinga

Swissmedic, the surveillance authority for medicines and medical devices, granted Linnea SA a narcotics license at the end of 2022.

This allows the company to help bring a pharmaceutical level of quality to this emerging cannabinoid industry, which is projected to grow from $28.26 billion in 2021 to $197.74 billion in 2028.

Linnea will begin producing GMP-certified high-THC active pharmaceutical ingredients (APIs) in 2023, becoming one of the first Swiss companies to do so, per a press release.

A narcotics license also allows Linnea to export their standardized and innovative high-THC APIs anywhere in the world where the importation of these products is legal.

“We are so honored to be granted a narcotics license in Switzerland, this opens up many new commercial possibilities for Linnea Cannabinoids and our customers,” Linnea CEO Susanne Caspar says. “High-quality cannabinoid ingredients are essential to producing the pharmaceutical products that patients need, and we are eager to contribute our expertise to this effort. We look forward to the opportunities this will afford us in creating new partnerships and continuing to innovate in the industry.” (Full Story)

In category:International
Next Post

Massive Los Angeles to London Cannabis Smuggling Ring Busted by Checked Baggage Security

As a result of recent arrests, travellers departing from Los Angeles and heading to London's Heathrow Airport may experience heightened security measures. Nine individuals were apprehended on suspicion of attempting to smuggle cannabis, a substance legal in California but illegal in…
Read
Previous Post

UK Pharma Co. Becomes First Ever Permitted By Gov To Produce High-THC Medicinal Cannabis

UK-based Celadon Pharmaceuticals PLC received the green light to produce high-THC medicinal cannabis in its Midlands facility, reported London South East. What Happened: This is the first company in the United Kingdom to be granted a Good Manufacturing Practice or GMP registration by the Medicines and Healthcare products Regulatory Agency…
Read
Random Post

Super Bowl LVIII: Great THC-Infused Game Day Munchies

This Sunday’s Super Bowl in Las Vegas—a rematch of football’s biggest game from four years ago, pitting the defending world champion Kansas City Chiefs taking on the San Francisco 49ers—is seemingly headed to be a sure-fire classic.  If they win,…
Read
Random Post

Cannabis Is Officially Legal In Germany – What You Need To Know

It’s official – with the clock striking midnight in Germany, and the date changing from March 31st to April 1st, the nation’s new adult-use cannabis legalization policy has become the law of the land. Adults (18 years old and older)…
Read
Random Post

Federal Agency Announces $1.5 Million In Funding For Research On Psychedelics To Treat Drug Addiction

A top federal health agency is soliciting proposals for a series of research initiatives meant to explore how psychedelics could be used to treat drug addiction, with plans to provide $1.5 million in funding to support relevant studies. As public…
Read
Random Post

GRN Holdings Completes Acquisition of Mendocino Green

GRN Holding Corporation, Inc. (OTC Pink: GRNF) has completed the purchase of Mendocino Green Inc, which includes a cultivation license, nursery license, and distribution license from one of the oldest cannabis license holders in California. With this acquisition complete, the company…
Read